Analyst Price Target is $8.33
▲ +158.00% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for AbCellera Biologics in the last 3 months. The average price target is $8.33, with a high forecast of $12.00 and a low forecast of $4.00. The average price target represents a 158.00% upside from the last price of $3.23.
Current Consensus is
Moderate Buy
The current consensus among 3 contributing investment analysts is to moderate buy stock in AbCellera Biologics. This rating has held steady since August 2024, when it changed from a Buy consensus rating.